IS7899A - Samverkandi samsetning sem felur í sér róflúmílast og (R.R)-formóteról - Google Patents

Samverkandi samsetning sem felur í sér róflúmílast og (R.R)-formóteról

Info

Publication number
IS7899A
IS7899A IS7899A IS7899A IS7899A IS 7899 A IS7899 A IS 7899A IS 7899 A IS7899 A IS 7899A IS 7899 A IS7899 A IS 7899A IS 7899 A IS7899 A IS 7899A
Authority
IS
Iceland
Prior art keywords
roflumilast
formoterol
synergistic composition
synergistic
composition
Prior art date
Application number
IS7899A
Other languages
English (en)
Other versions
IS2576B (is
Inventor
Beume Rolf
Bundschuh Daniela
Marx Degenhard
Weimar Christian
Wollin Stefan-Lutz
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of IS7899A publication Critical patent/IS7899A/is
Publication of IS2576B publication Critical patent/IS2576B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS7899A 2002-11-27 2005-06-20 Samverkandi samsetning sem felur í sér róflúmílast og (R.R)-formóteról IS2576B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02026504 2002-11-27
PCT/EP2003/013266 WO2004047828A1 (en) 2002-11-27 2003-11-26 Synergistic combination compresing roflumilas and (r.r) -formoterol

Publications (2)

Publication Number Publication Date
IS7899A true IS7899A (is) 2005-06-20
IS2576B IS2576B (is) 2010-02-15

Family

ID=32338001

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7899A IS2576B (is) 2002-11-27 2005-06-20 Samverkandi samsetning sem felur í sér róflúmílast og (R.R)-formóteról

Country Status (32)

Country Link
US (1) US20060199865A1 (is)
EP (1) EP1567140B1 (is)
JP (1) JP2006508993A (is)
KR (1) KR20050094810A (is)
CN (1) CN1713902A (is)
AT (1) ATE399544T1 (is)
AU (1) AU2003288169B8 (is)
BR (1) BR0316475A (is)
CA (1) CA2506956C (is)
CO (1) CO5690571A2 (is)
CY (1) CY1110368T1 (is)
DE (1) DE60321954D1 (is)
DK (1) DK1567140T3 (is)
EA (1) EA009990B1 (is)
ES (1) ES2309374T3 (is)
HK (1) HK1081862A1 (is)
HR (1) HRP20050580B1 (is)
IL (1) IL168307A (is)
IS (1) IS2576B (is)
MA (1) MA27538A1 (is)
ME (1) ME00488B (is)
MX (1) MXPA05005438A (is)
NO (1) NO334148B1 (is)
NZ (1) NZ540658A (is)
PL (1) PL214869B1 (is)
PT (1) PT1567140E (is)
RS (1) RS51082B (is)
SI (1) SI1567140T1 (is)
TN (1) TNSN05130A1 (is)
UA (1) UA83017C2 (is)
WO (1) WO2004047828A1 (is)
ZA (1) ZA200503307B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
MXPA04008070A (es) 2003-03-10 2004-11-26 Altana Pharma Ag Novedoso proceso para la preparacion de roflumilasto.
JP5383183B2 (ja) 2005-03-16 2014-01-08 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストを含有する矯味された剤形
WO2013077830A1 (en) * 2011-11-25 2013-05-30 Mahmut Bilgic Synergistilly active combinations of roflumilast and carmoterol
CN103784443A (zh) * 2014-02-18 2014-05-14 青岛市城阳区人民医院 一种包含沙美特罗和罗氟司特的药物组合产品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
ES2178015T3 (es) * 1996-11-11 2002-12-16 Sepracor Inc Procedimiento de preparacion de isomeros de formoterol opticamente puros.
PT977577E (pt) * 1997-02-17 2007-02-28 Altana Pharma Ag Composições para o tratamento de ards ou irds contendo 3-(ciclopropilmetoxi)-n- (3,5-dicloro-4-piridinil)-4-(difluorometoxi) benzamina e tensioactivo pulmonar.
AU6823098A (en) * 1997-02-28 1998-09-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
PL346271A1 (en) * 1998-08-26 2002-01-28 Smithkline Beecham Corp Therapies for treating pulmonary diseases
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
MXPA02001830A (es) * 1999-08-21 2002-08-12 Byk Gulden Lomberg Chem Fab Combinacion sinergica de inhibidores de pde y agonista de beta 2 adrenoceptor.
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
ATE381537T1 (de) * 2001-03-22 2008-01-15 Glaxo Group Ltd Formanilid-derivative als beta2-adrenorezeptor- agonisten
CA2445839A1 (en) * 2001-04-30 2002-11-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha

Also Published As

Publication number Publication date
MA27538A1 (fr) 2005-09-01
KR20050094810A (ko) 2005-09-28
ATE399544T1 (de) 2008-07-15
NO334148B1 (no) 2013-12-16
HRP20050580A2 (en) 2006-08-31
DE60321954D1 (de) 2008-08-14
IS2576B (is) 2010-02-15
PL375632A1 (en) 2005-12-12
CA2506956C (en) 2012-10-02
NZ540658A (en) 2007-03-30
IL168307A (en) 2010-12-30
UA83017C2 (uk) 2008-06-10
EP1567140A1 (en) 2005-08-31
AU2003288169B8 (en) 2010-08-26
PT1567140E (pt) 2008-09-24
ZA200503307B (en) 2006-11-29
PL214869B1 (pl) 2013-09-30
TNSN05130A1 (en) 2007-05-14
MXPA05005438A (es) 2005-08-03
US20060199865A1 (en) 2006-09-07
WO2004047828A1 (en) 2004-06-10
NO20053023L (no) 2005-06-20
JP2006508993A (ja) 2006-03-16
HRP20050580B1 (hr) 2014-04-11
CN1713902A (zh) 2005-12-28
DK1567140T3 (da) 2008-11-03
SI1567140T1 (sl) 2008-12-31
CA2506956A1 (en) 2004-06-10
CO5690571A2 (es) 2006-10-31
EP1567140B1 (en) 2008-07-02
AU2003288169A1 (en) 2004-06-18
BR0316475A (pt) 2005-10-11
EA009990B1 (ru) 2008-04-28
CY1110368T1 (el) 2015-04-29
RS51082B (sr) 2010-10-31
EA200500865A1 (ru) 2005-12-29
ES2309374T3 (es) 2008-12-16
HK1081862A1 (en) 2006-05-26
AU2003288169B2 (en) 2010-01-07
ME00488B (me) 2011-10-10
RS20050383A (en) 2007-08-03

Similar Documents

Publication Publication Date Title
IS2575B (is) Ný samverkandi samsetning sem felur í sér róflúmílast og formóteról
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
BR0013478A (pt) Combinação sinergìstica
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
IS7899A (is) Samverkandi samsetning sem felur í sér róflúmílast og (R.R)-formóteról
NZ591136A (en) A composition for treating aids and associated conditions comprising plant extracts
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
PT1490049E (pt) Citalopram para o tratamento da pre3ssao sanguinia elevada.